ROTEM Coagulation Guide
Interpret rotational thromboelastometry (ROTEM) results and guide targeted coagulation therapy. Separate fibrinogen deficiency from platelet dysfunction for goal-directed hemostatic resuscitation.
Based on: ESC 2022 · ESAIC
Input
Overview
Rotational thromboelastometry (ROTEM) provides multi-channel viscoelastic assessment of whole blood haemostasis. By comparing EXTEM (total clot strength) with FIBTEM (fibrinogen-only channel, platelets blocked), ROTEM directly separates platelet dysfunction from fibrinogen deficiency — a key advantage over single-channel assays and conventional coagulation tests.
Evidence Summary
Evidence Snapshot
Multiple studies show that ROTEM-guided goal-directed haemostatic therapy reduces allogeneic blood transfusion. Importantly, this reduction occurs without increasing mortality or thromboembolic complications. Evidence is strongest in cardiac surgery and major trauma.
Key Study
A 2016 Cochrane meta-analysis (Afshari et al.) evaluated viscoelastic-guided transfusion strategies. Compared with conventional care, ROTEM/TEG-based algorithms significantly reduced red blood cell transfusion.
Guideline Position
The ESA/ESAIC 2023 guideline recommends viscoelastic testing for perioperative bleeding management. ROTEM-guided haemostatic therapy is supported as a Class I recommendation in appropriate clinical settings.